1. Home
  2. SNEX vs CRL Comparison

SNEX vs CRL Comparison

Compare SNEX & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo StoneX Group Inc.

SNEX

StoneX Group Inc.

HOLD

Current Price

$77.30

Market Cap

9.1B

Sector

Finance

ML Signal

HOLD

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$261.79

Market Cap

10.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNEX
CRL
Founded
1924
1947
Country
United States
United States
Employees
5400
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
10.8B
IPO Year
1996
1999

Fundamental Metrics

Financial Performance
Metric
SNEX
CRL
Price
$77.30
$261.79
Analyst Decision
Strong Buy
Buy
Analyst Count
1
12
Target Price
$81.33
$198.27
AVG Volume (30 Days)
883.7K
786.4K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.74
N/A
Revenue
$132,378,200,000.00
$1,857,601,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.17
$3.04
P/E Ratio
$20.10
N/A
Revenue Growth
32.53
10.48
52 Week Low
$68.00
$144.26
52 Week High
$141.99
$242.73

Technical Indicators

Market Signals
Indicator
SNEX
CRL
Relative Strength Index (RSI) N/A 76.17
Support Level N/A $153.47
Resistance Level N/A N/A
Average True Range (ATR) 0.00 7.39
MACD 0.00 1.28
Stochastic Oscillator 0.00 100.00

Price Performance

Historical Comparison
SNEX
CRL

About SNEX StoneX Group Inc.

StoneX Group Inc is a brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: